Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Jinsheng Biotechnology is a Chinese life sciences company specializing in the research, development, and manufacturing of in vitro diagnostic (IVD) raw materials and point-of-care testing (POCT) solutions. Founded in 2016, the company provides a wide range of biological reagents, including high-quality recombinant proteins, monoclonal antibodies, and antigens used in diagnostic kits. Their product portfolio covers various clinical areas such as infectious diseases, cardiac markers, inflammation, and tumor markers. Jinsheng Biotechnology operates as a key supplier to diagnostic kit manufacturers globally, leveraging its expertise in protein expression and antibody purification. The company is headquartered in Guangzhou and maintains a strong focus on quality control and technological innovation in the diagnostic reagent sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Jinsheng Biotechnology.